The success of cryoablation of the pulmonary vein isolation (PVI) is dependent on transmural and circumferential ice formation. We hypothesize that rising impedance recorded from a ring electrode placed 2 mm from the cryoballoon signifies ice formation covering the balloon surface and indicates ice expansion. The impedance level enables titration of the cryoapplication time to avoid extracardiac damage while ensuring PVI.
T he efficacy and safety profile of the cryoballoon for pulmonary vein isolation (PVI) has been documented in multiple clinical studies. 1, 2 Presently, the time of the cryoapplication is commonly set at 180 seconds, with early termination if the phrenic or the esophagus is affected. In a recent study, time to pulmonary vein (PV) conduction block was noted within 60 seconds, and the addition of 120 seconds to the cryoapplication resulted in high rate of success. 3 Despite safety measures to avoid extracardiac injuries associated with the use of the cryoballoon, complications are still reported. 3, 4 The ideal approach to avoid complications is to limit the ice formation to the cardiac tissues by titrating the cryoapplication time, and as a result, limit ice expansion. Although blood and vascularized muscle tissues are highly electrically conductive, frozen blood and tissue products are poor conductors. When a portion of a circuit is exposed to ice formation, the impedance of the circuit increases. Impedance continues to increase as ice thickens. 5 This is a welldocumented phenomenon that has been applied to a variety of needs, such as tracking ice on airplane wings, frost formation on bridges, ice thickness on the outside of spacecraft, and in cancer cryotherapeutics. [6] [7] [8] We apply this principle to a more focused and smaller scale to monitor ice progression at the anterior surface of the cryoballoon. Although the ideal approach is to directly measure impedance and temperature from the balloon-tissue interface, placing sensors on the balloon surface is technically challenging and is incrementally more expensive. The proposed approach is simpler and easier to implement ( Figure 1 ). It was hypothesized that rising impedance recorded from a ring placed on the catheter shaft anterior to the cryoballoon surface signifies circumferential ice formation at the balloon PV interface extending over the anterior balloon and cov-
WHAT IS KNOWN?
• Extracardiac injuries and associated complications are still reported with the use of cryoballoons.
• The ideal approach to avoid complications in cryoablation is to find an appropriate titration of cryoapplication time.
WHAT THE STUDY ADDS?
• Impedance rise recorded from a ring placed on the catheter shaft anterior to the cryoballoon surface signifies circumferential ice formation and is an indicator of ice growth and lesion formation.
• The principal observation is that once the impedance rises >500 Ω in <90 seconds of freeze time, the cryoapplication can be terminated at 90 seconds with 100% likelihood of achieving pulmonary vein isolation.
Figure 1. Cryoballoon.
A 28-mm cryoballoon instrumented with an electrode ring placed on the shaft 2 mm from the anterior surface of the balloon. An additional electrode was placed proximally behind the balloon and was used as the reference electrode for the impedance measurements.
ering the ring electrode. The increasing impedance of the distal ring is an indicator of ice growth and lesion formation, which can be used to titrate the cryoapplication time.
METHODS
The data that support the findings of this study are available from the corresponding author on reasonable request. As shown in Figure 1 , an electrode ring was placed on the shaft 2 mm from the anterior surface of the balloon. An additional electrode was placed proximally behind the balloon and was used as the reference electrode for the impedance measurements.
The rings were connected to a current source (Keithley: Model 6221 DC and AC Current Source) and multimeter (Keithley: Model 2100 6 ½ Digit Multimeter) while continuous measurements are taken with an add-on program through Microsoft Excel. This allows for the impedance to be measured before, during, and after the cryoapplication has been initiated. In addition, intraballoon temperature and cryoapplication time were recorded through the CryoConsole (Medtronic, Minneapolis, MN).
All procedures were performed in compliance with the American Heart Association's guidelines for animal research and approved by the Animal Care Committee of the University of Illinois at Chicago. Canines (30-35 kg) underwent anesthesia induction with intravenous propofol (0.5 mg/kg) and maintenance with inhaled isoflurane 1.00% to 1.75% via endotracheal intubation. Intra-arterial blood pressure and esophageal temperature monitoring were performed throughout the entire experimental protocol, and core temperature was maintained at 38.0°C±1.3°C using a heating blanket.
A 20-pole deflectable catheter was inserted into the external jugular vein and positioned in the high right atrium extending into the coronary sinus as a reference.
Trans-septal puncture was performed, and a 14F deflectable delivery sheath was inserted into the left atrium (LA). Before insertion of the cryoballoon, the chamber anatomy, PV orifices, and LA voltage maps were generated using a 20-pole deflectable catheter and the EnSite NavX 3D (St. Jude Medical, St. Paul, MN) navigation system. A 0.035" guidewire was advanced into the targeted vein, and the cryoballoon instrumented with the ring electrodes was inserted and positioned to engage the PV. In 101 cryoapplications, the 23-mm balloon was used, and in 10, the 28-mm balloon was used.
The cryoballoon was inflated, and PV occlusion was assessed using a cold saline technique. 9 The cold saline technique quantifies balloon-tissue contact and provides an assessment of leaks surrounding the balloon without the use of fluoroscopy and radiopaque contrast. Cryoballoons instrumented with an anterior thermocouple can detect the temperature decrease associated with an injection of 5 cc of 4°C saline solution while the balloon is positioned to occlude the PV. The cold saline injection results in characteristic temperature changes that correlate with the quality of the occlusion. Good and fair occlusions have larger temperature drops and slower temperature rewarming versus poor occlusion. When the PV is occluded, rewarming occurs mainly because of the influx of body heat rather than blood flow. During poor occlusion, the temperature drop is minimal, and the recovery is fast because of the blood flow that washes the cold saline away. When good and fair occlusions are paired with an ablation, they yield a much greater chance of successful circumferential and transmural lesion. Conversely, ablations paired with poor occlusion have low rates of successful ablation. 9 With good, fair, and poor occlusion, the maximal postinjection PV temperature dropped (ΔT) 7.7°C±4.4°C, 5.8°C±5.0°C, and 3.4°C±2.3°C; % at 5 seconds postnadir temperature, injection temperature recovered 15%±12%, 31%±23%, and 45%±30%, respectively.
Two cryoapplications were applied to each vein. The freeze time was titrated based on the distal ring electrode impedance during cryoapplication. The change in impedance from the post-occlusion baseline (prefreeze) to the termination of the ablation was divided into 3 ranges: ≥500 Ω (high impedance change), 200 to 500 Ω (medium impedance change), <200 Ω (low impedance change). Based on the previous research, 9 the threshold for termination of ablation was found to be 500 Ω. Although there is a strong association between good occlusion and high impedance change and poor occlusion and low impedance change, fair occlusion can result in either moderate or high impedance changes (Table) . A rapid impedance rise to ≥500 Ω required a minimum of 90 seconds freeze time; in cases where the freeze time was <90 seconds even with high impedance, PV gaps were noted after ≥4 weeks of recovery. Cryoapplication time of 180 seconds was maintained with impedance of <500 Ω.
The ring electrode impedance data, cryoapplication time, internal temperature at 30 and 60 seconds of freeze, the nadir temperature achieved, and the thaw time to 0°C were recorded for each cryoapplication. As shown in Figures 2 and 3, the right superior pulmonary vein (RSPV) in the canine has superior, middle, and inferior branches that join to create a large antral base. The RSPV in this model presented with the greatest challenge to occlude and ablate. Often, this vein required subveins be treated individually. Ablations were placed in 2 primary locations: superior/middle branches and another in the inferior branch. As shown in the Figures 2 to 4 and reflected in the data, 5 of 11 (45%) PVI failures were associated with this vein.
After 38±6 days of recovery, PVs voltage maps and conduction blocks were defined by sleeve electrical activity and pacing within the PV and atria to assess trans-PV sleeve conduction. Phrenic nerve was stimulated ensuring diaphragmatic activation. The explanted heart, esophagus, and lungs were closely inspected for cryoinjury. The tissues were stained with tetrazolium blue. The tissue at the base of each ablated vein as demarcated by the tetrazolium blue stain were photographed, sectioned, and stained with Masson trichrome stain for microscopic analysis.
Statistics
Nonparametric Kruskal-Wallis test results and pairwise 2-sample Wilcoxon comparisons were used to determine whether there were significant differences between mean values obtained from recordings for each of the freeze cycles ring impedance, console temperature, and thaw times. All data are expressed as a mean±SD. A P≤0.05 was deemed significant. SAS 9.4 software was used for all statistical computations. The capability of each impedance level to predict PVI success was validated by the electrical mapping, pacing, and histopathologic analysis of the PVs ostia as well as the intraballoon freeze and thaw characteristics. Examples of the impedance profiles (A) recorded from the distal to proximal rings electrodes, internal balloon temperatures, thaw time (B and C), the inverted tetrazolium-stained pulmonary veins (PVs), and atria along with the PVs trichrome-stained histology shown on (D). The right superior superior (RSS) and right superior middle (RMS) PVs cryoapplication was initiated with fair occlusion. The cryoablation resulted in a low internal balloon temperature (−77°C) and slow thaw time, the impedance rise was slow reaching 491 Ω at 180 s. In the right inferior (RI) PV, the cryoapplication was initiated with good occlusion. The impedance rise was initially slow with sudden takeoff exceeding 500 Ω at 84 s and termination of the cryoapplication at 90 swith impedance of 1877 Ω. The left inferior (LI) PV exhibit impedance profile of slow rise achieving 371 Ω at 180 s of cryoapplication. Attempts to ablate the right superior inferior (RSI) PV failed secondary to poor occlusion exhibiting only 92 Ω impedance rise, low internal balloon temperature decline, rapid thaw time, and unablated tissues. The ablated PVs are fully patent and are not distinguishable as to the extent and character of the fibrous tissues. The left superior (LS) PV was not ablated with fully intact PV sleeve. 
RESULTS
As shown in the Table, in 12 animals, 111 cryoapplications were performed averaging 2 per vein in 57 PVs. In 24 cryoapplications, the impedance rise was rapid and increased by 500 Ω before or at 90 seconds averaging 82±11 seconds (ranging from 61 to 90 seconds). If the impedance achieved 500 Ω at <90 seconds, the freeze time was maintained for 90 seconds. In 4 PVs (not included in the table), the cryoapplication was terminated as soon as the change in impedance increased by 500 Ω, which was reached before 90 seconds of cryoapplication. The average time to the 500 Ω increase was 67±11 seconds ranging from 52 to 78 seconds. The veins ablated included 1 right inferior PV (mean diameter of 11.1±1.4 mm), 1 left superior PV (8.4±2.3 mm), and 2 RSPVs (12±0.7 mm). In these 4 applications, PVI was not achieved after >4 weeks of recovery (Figure 4 ), whereas cryoapplications with a >500 Ω increase and 90-second ablation time resulted in 100% success rate. In 90-second titrated lesions, the impedance level was 2916±2495 Ω ranging 555 to 8328 Ω, nadir console temperature −60°C±9°C, and thaw duration to 0°C of 13±4 seconds. These internal balloon temperatures were the lowest and slowest to thaw. Within the 2 groups of cryoapplications reaching impedance values ≥500 Ω (90 versus >90 seconds of cryoapplication), there were no significant statistical differences between any of the internal balloon parameters regardless of the duration of cryoapplication. Ablations reaching a change in impedance of ≥500 Ω within 90 seconds resulted in PVI in 12 of 12 veins (100%) while ablations reaching a change in impedance of 500 Ω in >90 seconds (freeze time of 142.6±29.3 seconds; range 101 to 180 seconds) resulted in PVI in 18 of 20 veins (90%).
A total of 35 cryoapplications were performed at an impedance range of 200 to 500 Ω and 180 seconds freeze time, and the average recorded values were as follows: impedance change of 296±90 Ω, nadir temperature of −55°C±9°C, and thaw time to 0°C was 8±4 seconds. Only 1 application was found to have poor occlusion while 15 were rated good and 19 were rated fair. At this impedance, range 15 of 17 veins (86.8%) PVI was documented.
In 8 veins, there were 19 cryoapplications, 18 of which were poor occlusions and 1 fair occlusion. The impedances of these runs increased by <200 Ω with 180-second freeze time. Along with the low impedance changes, suboptimal console temperature and rapid thaw times (impedance change, 79±58 Ω; nadir console temperature, −46°C±8°C; and thaw to 0°C, 6±3 seconds) were recorded. These values are significantly different (except for the internal balloon temperature at 30 seconds) than cryoapplications with impedance changes >200 Ω. More importantly, only 1 of 8 veins (14%) resulted in successful PVI.
In this investigation, the internal balloon temperature at 30 seconds into the freeze was not significantly different between the ranges of impedance rise. At 60 seconds after the initiation of the freeze, however, all the internal balloon parameters comparing impedance changes of <200 Ω (associated with poor occlusion) to all cryoapplications with impedance rise of >200 Ω were statistically significant with lower temperatures and slower thawing rates (Table) . Figures 2 and 3 are examples of the impedance profiles recorded from the distal to proximal rings electrodes, internal balloon temperatures, thaw time, the inverted (showing the endocardial surface) tetrazolium blue-stained PVs, and atria along with the PVs trichromestained tissues. As shown in Figure 2 , the right superior superior/right superior middle PV cryoapplication was initiated with fair occlusion. The cryoapplication resulted in low internal balloon temperature (−77°C) and slow thaw time. The impedance rise was slow achieving 491 Ω at 180 seconds. In contrast, in the right inferior pulmonary vein, the cryoapplication was initiated with good occlusion. The impedance rise was initially slow with a sudden takeoff exceeding 500 Ω at 84 seconds and termination of the cryoapplication at 90 seconds, with an impedance that rose from 500 to 1877 Ω within 8 seconds. The left inferior vein impedance rose slowly, achieving 371 Ω at 180 seconds of cryoapplication. Attempts to ablate the right superior inferior failed because of poor occlusion exhibiting only 92 Ω impedance rise, low internal balloon temperature decline, rapid thaw time, and unablated tissues. The ablated PVs are fully patent and are not distinguishable as to the extent and character of the fibrous tissues. PVI failure associated with poor PV occlusion is shown in Figure 3 . Despite of the diversity of nadir internal balloon temperatures ranging from −38°C to −58°C and thaw times to 0°C ranging 3 to 8 seconds, the impedance hardly increased throughout the cryoapplication resulting in only segmental lesion, and none of the RS veins were circumferentially ablated. The rate and level of impedance rise provide definition of the ice formation, correlates well with occlusion levels and ultimately success or failure of PVI.
Pathological and Histological Analyses
After 38±6 days, stimulation of the right phrenic nerve activated the diaphragm in all animals. The heart, lung, and esophagus were removed and were closely examined for extracardiac damage. The esophagus was stained with tetrazolium blue. No damage could be identified in any of the extracardiac tissues. As shown in Figure 2 , no pathological and histological differences were noted comparing the extent and character of the tissues ablated after rapid impedance rise of >500 Ω and 90 seconds versus slow impedance rise of 200 to 500 Ω and 180 seconds.
DISCUSSION
The principal observation is that once the impedance level has reached ≥500 Ω in <90 seconds of freeze time, the cryoapplication can be terminated at 90 seconds with 100% likelihood of achieving sustained PVI. When the impedance reached 500 Ω at >90 to 180 seconds or was between 200 and 500 Ω within 180 seconds of the freeze time, the success rate was 90% and 86.8%, respectively. An impedance of <200 Ω and 180-second freeze times was likely to fail with only 14% success.
Bases for the Impedance Ranges
As noted in the introduction, ice is a poor conductor. 5 As ice encroaches onto the ring, electrode positioned on the closest position possible to the anterior surface of the balloon the impedance rises slowly as the exposed surface area of the electrode is reduced. However, once the ice entirely covers the ring electrode, the impedance rises rapidly as shown in Figure 2 . By the time the cryoapplication is stopped, the impedance may reach several thousand ohms. The time between reaching the 500 Ω impedance rise to termination was 8±11 seconds (in the PVs that the 500 Ω was recorded <90 seconds) and with an average impedance rise of 2916±2495 Ω. Given the rapid impedance rise and the short time frame, the chances of significant ice expansion is small. Using this approach, no extracardiac injuries were documented.
Ice formation around the cryoballoon in most PV applications is unlikely to be perfectly uniform in thickness. Factors that influence the ice thickness are as follows: PV occlusion and any leaks, ostial versus deep PV position, balloon to PV angular position, PV size, LA and PV blood flow and volume, pleural heat, and proximity to pulmonary vasculature. The main impedance value is defined by the path of least resistance, via the section of the anterior ring that is exposed or has the thinnest ice and the proximal ring electrode positioned in the LA. For ice to form, the environment needs to be hydrated. Ice would not form in dry air; however, in high humid air, such as the pleural space, ice spicules will develop around the PV/ pericardium/pleural space, and ice will slowly build up.
An important element that may impact the ice formation at the balloon/PV interface and ice thickness on the ring electrode is the balloon position relative to the PV. In the best circumstances, if the balloon equator is at 90° to the PV ostia with total occlusion, ice is formed around the balloon/PV interface and extends to the ring (please note that in the Arctic Front Advance Cryoballoon, the liquid N 2 O spray cools the anterior surface). With total occlusion, this position is likely to yield the fastest and highest impedance rise. In contrast, if the balloon's position in the vein is angulated, it is harder to achieve PV occlusion. In addition, a portion of the spray of liquid N 2 O may now be exposed to the LA blood flow while a portion of the poorly cooled balloon surface (in the back of the spray) is now within the vein. Such a position is likely to yield to uneven ice formation and smaller impedance rise, whereas the rapid ice formation with it the rapid impedance rise is likely associated with ≈90° balloon PV ostia position.
Factors That Define Permanent Cryo Lesion
In some situations, temperatures of tissues undergoing cryoapplication have been shown to range from just below +10°C to just under 0°C near the balloon-tissue interface with only a small number falling significantly below 0°C. 10 At such temperatures, it is unlikely that lethal ice will form. 11 Proper ablation requires a mixture of ice formation and exposure time. [9] [10] [11] [12] Ablations in this study terminated before 90 seconds failed to result in PVI (5 veins). However, holding the ablation to at least 90 seconds has resulted in success rates of 100%, suggesting that a minimum duration is necessary. Future studies will require determining exactly how short this duration may be.
Factors Impacting the Impedance
The impedance measurement is defined by multifactorial elements that are fixed, such as the ring electrode surface area and material, unaffected blood and tissues at body temperature, whereas others are changing because of the ice formation. Among other factors, the ring electrode impedance is an inverse relationship to its surface area. As the ring conductor is being covered by the expanding ice, the area of a high conductance (exposed metal) diminishes and the impedance increases, and a dramatic increase in the impedance is noted once all the ring surface is totally covered by the ice.
An additional critical element of successful ablation is the use of an appropriately sized balloon. In a 30-to 35-kg canine, the PV diameter ranges from 6.1 to 13 mm. The RSPV and right inferior pulmonary vein are the largest veins measuring 11 to 13 mm in diameter. We have used the 28 mm in 10 PVs 5 in the RSPV. High impedance was achieved in the RSPV and good occlusions using the 28-mm balloon (3833±2894 Ω). Using the 23-mm balloon in 40 cryoapplications and good occlusions in the RSPV, the impedance increase was 2084±3011 Ω. Achieving a good stable occlusion in smaller sized veins with the 28 mm balloon was a challenge and resulted in replacing the 28-mm balloon with 23 mm.
Ring Electrode Impedance and Cryoconsole Temperatures
Poor occlusion and the resulting low impedance do correlate with the console internal balloon temperatures exhibiting significantly lower freeze temperature and rapid thaw times versus the fair and good occlusions. In addition, the PVI yield corresponds to the freeze characteristics both by the ring impedance and the internal balloon temperatures. In clinical studies that resulted in successful PVI, the balloon internal temperature during the freeze cycle achieved greater than −40°C at 60 seconds and a nadir temperature of −51.5°C±4.7°C. 13 Although the internal balloon temperature may indicate an adequate freeze, it does not provide the operator with any indication when the cryoapplication can be terminated and avoid extracardiac injuries. In addition, thaw times reported in this study correlated well with clinical targets. Successful PVI in the clinical model had thaw duration to 0°C of 14.8±10 seconds and in reconnected veins, thaw durations were 7±2 seconds.
14 Thaw times, however, are a strong proven indicator of PVI success but are calculated after the formation of a lesion. The impedance provides real-time assessment of the ice formation.
Single Cryoapplication Preliminary Outcome
The bulk of this study investigates the effect of 2 ablations per vein which was at the time the standard clinical practice. Presently increasing number of clinicians apply a single 3-minute ablation per vein. In our own ongoing studies, we are investigating the effect of a single ablation per vein titrated based on impedance. Early results indicate 7 of 7 veins (100%) achieving >500 Ω and titrated to ≥90 seconds resulted in chronic PVI. Two additional veins were fully ablated (achieved PVI) with >200 impedance change using 180 seconds of ablation. These initial results suggest that a single cryoapplication may suffice to achieve PVI when the impedance rises ≥500 Ω in ≤90 seconds.
A recent publication examined the clinical efficacy of the cryoballoon PVI in an effort to titrate the cryoablation dosing to efficacy. The average duration of an application using the time to PVI of <60 seconds plus 120 seconds was 149±34 seconds with acute PVI isolation of 98.9%. 3 This is not significantly different from 180 seconds and may allow for ice to expand further than needed. In this study, persistent phrenic nerve palsy was documented in 0.6% and 12-month freedom from all atrial arrhythmias was reported as 82.5%. 3 The time to isolation identifies that tissue is either being stunned or ablated. For permanent PVI, there must be a circumferential tissue temperature of less than −20°C with the exposure time a function of the tissue temperature. The addition of 120 seconds to the ablation time is an effort to ensure that ice formation is uniform. However, this value is arbitrary, and the extension of time may allow for ice to propagate to extracardiac tissues. Direct measures of ice formation would be much more precise in guiding the application and define the ablation efficacy. We should strive to develop the means that guide the ablative technology as precisely as possible to achieve irreversible targeted myocardial tissue distraction. The impedance of ice formation provides that measure.
Limitations
The study is a proof of concept performed in an animal model. Human clinical trials will be needed. The balloon instrumented by the ring electrode is a prototype based on the Arctic Front Advance catheter design. The impedance ranges and the time to cryotermination based on the impedance levels may need further finetuning in the human. However, the ablation method used in this investigation establishes initial parameters for the application of this concept in human cryoballoon PVI procedures. Furthermore, at the initial phase of this investigation, we made an effort to record the PV potentials in an effort to correlate the impedance rise and the timing to PVI; however, using the standard Arctic Front Advance instrumented with an Achieve catheter, we could not consistently record the PV muscle sleeve potentials because of the anatomic limitations of the canine model (short PV sleeves).
CONCLUSIONS
Presently, the time of the cryoapplication is commonly set at 180 seconds. Recently, using the time to PVI with abbreviated application to tailor the total ablation time is gaining interest as a means to limit phrenic or the esophagus involvement. Despite safety measures to avoid extracardiac injuries associated with the use of the cryoballoon, complications have been reduced but are still reported.
In this investigation, for the first time, impedance measurements from a ring electrode placed near the anterior surface of the balloon provided valuable realtime data on the ice propagation. This real-time measure can be used to guide cryoapplication and terminate applications earlier than current methods, further reducing the risk of extracardiac damage, while ensuring PVI.
The principal observation is that once the impedance level has reached ≥500 Ω in <90 seconds of freeze time, the cryoapplication can be terminated at 90 seconds with 100% likelihood of achieving sustained PVI. When the impedance reached 500 Ω at >90 to 180 seconds or was not achieved within 180 seconds of the freeze, the success rate was 90% and 86.8%, respectively. An impedance of <200 Ω and 180-second freeze times would likely fail with 14% success. Successful ablations closely related to the quality of the occlusion.
